5069Reversal of apixaban and rivaroxaban anticoagulation by andexanet alfa in ANNEXA-A&R as assessed by non-tissue factor (TF)-initiated thrombin generation independent of TF pathway inhibitor (TFPI). (28th August 2018) - Lu, G; Lin, J; Bronson, M; Crowther, M; Conley, P B; Curnutte, J T